RECENT NEWS

Pfizer and Thermo Fisher Scientific have announced they have entered into a collaboration agreement to help increase local access to next-generation sequencing (NGS)-based testing for lung and breast cancer patients in more than 30 countries across Latin America, Africa, the Middle East and Asia where advanced genomic testing has previously been limited or unavailable.

Revvity has been officially launched as a science-based solutions company that leverages innovation across life sciences and diagnostics to help improve lives everywhere. The company was previously affiliated with PerkinElmer.

The British In Vitro Diagnostics Association (BIVDA) commissioned the University of Nottingham to produce an independent White Paper examining the UK Government’s procurement of COVID-19 tests during the pandemic, which has now been published.

Fast-growing health technology company Magentus is continuing its global expansion on the back of a series of major acquisitions and significant contract wins. Magentus is consolidating leading health technology companies Citadel Health, Wellbeing Software and Genie Solutions under one new brand, drawing together operations across the UK and Australia to take its services into new regions.

Digital pathology firm Paige has announced a new collaboration with Visiopharm, an artificial intelligence (AI)-driven precision pathology software provider, to bring a wider range of AI products to doctors and patients.

Global Access Diagnostics (GADx) has announced that co-founder Mark Davis is stepping down as CEO after 20 years, having founded the company as Mologic in June 2003, alongside his father and industry leader Professor Paul Davis.

Aiosyn, a software company that develops AI-powered pathology software, has announced the integration of its AI-powered automated quality control (QC) algorithm in the Sectra Amplifier Marketplace.

Clinisys has acquired Promium, a Bothell, Washington, USA-based leading provider of laboratory information management systems dedicated to supporting environmental, water, wastewater and other analytical testing laboratories that protect health and safety.

Roche has announced the launch of the Institute of Human Biology (IHB) focusing on advancing research in the field of human model systems such as organoids. Leveraging human model systems, the institute aims to accelerate drug discovery and development by improving the understanding of how organs function and how diseases develop, ultimately bringing medicines to patients faster.

Gyros Protein Technologies, a provider of peptide synthesisers and reagents and a pioneer in automated nanolitre-scale immunoassays, has announced the introduction of Gyrolab Generic Cyno Anti-Drug Antibodies (ADA) Kit Reagents, for the detection of circulating immune complexes of human IgG with cyno anti-human IgG.

Hospitals are now being asked to work towards a 10-day turnaround when delivering diagnostic test results to patients who have received an urgent referral for suspected cancer, as part of new plans to see and treat people for cancer as early as possible.

A statutory instrument has been laid in the UK Parliament, which will enable an extended timeframe for acceptance of CE-marked medical devices on the Great Britain market, the MHRA has announced.

US-based health services company Curative has announced the spin-off of Sensible Diagnostics, with the aim of commercialising its ground-breaking point-of-care PCR testing platform.

Pathology diagnostics service provider Diagnexia UK - owned by Deciphex – recently celebrated the launch of its expanded facility at Exeter Science Park.

HORIBA UK Veterinary is supporting Strangles Awareness Week 2023 to educate and improve biosecurity for this devastating equine specific disease.

Tecan and DYNEX Technologies have announced a partnership to broaden the availability of ELISA products in the US. Customers will now have direct access to Tecan’s ELISA-related kits and comprehensive portfolio of reagents alongside DYNEX's fully automated ELISA workstations.

Evident’s new Slideview VS200 v. 4.1 software supports a host of new features, including the SILA optical sectioning device that enables users to obtain high-contrast images from deep within a sample.

The Council of Europe Steering Committee for Human Rights in the fields of Biomedicine and Health (CDBIO) has published a report regarding the public dialogue on genomic medicine – marking the date of the 70th anniversary of the discovery of the DNA double helix.

The IBMS has been entrusted with running Harvey’s Gang laboratory tours to ensure many more young patients and members can benefit from the initiative. As the founder and IBMS member Malcolm Robinson and the Harvey’s Gang trustees have decided to wind down the charity, the IBMS is stepping in to become the new custodian.

Digital pathology and image management firm Indica Labs, and Lunit, a leading medical AI software platform company focused on cancer biomarkers have announced an agreement to provide a fully interoperable solution between Indica Labs’ HALO AP image management software platform and Lunit’s suite of AI pathology products.